Revealing Covid-19 Fraud and Collusion: Evidence of a Global Crime Against Humanity

Sasha Latypova's revelations

I am reposting this important video and article about the work of my colleague Sasha Latypova. If you have not seen our interview, please review it here:

Conversations with Pharma Insider Sasha Latypova - Nanotech in C19 vials, Regulatory Fraud, Bad Manufacturing Practices, DOD contracts & more

For the full link article please click this link here:

Revealing Covid-19 Fraud and Collusion: Evidence of a Global Crime Against Humanity

Alexandra (Sasha) Latypova is well placed to recognise and speak about the Covid-19 fraud taking place today under the guise of “public health”. Retired prior to the Covid-19 pandemic, she has 25 years experience as a pharmaceutical industry executive, working in data analysis and clinical trial research and development.

Latypova recently testified to the Corona Investigative Committee on evidence of the Covid-19 inoculations including research and regulatory fraud, reckless manufacturing practices and evidence of adverse events. She writes for Life Site News.

On 30 September 2022 she delivered a presentation titled C-19 Injections, Regulatory and Manufacturing Fraud: Evidence of collusion between the manufacturers, global regulatory agencies and the US Department of Defense. This crucial information ties in with NZDSOS’ concerns regarding the contamination of “vaccine” vials, determinedly ignored by regulatory authorities, and associated health harms to the New Zealand public, including deaths and injuries, which are also determinedly ignored.

To summarise the hour-long presentation briefly, the following evidence is presented:

• Complete lack of compliance of the Covid-19 “vaccine” products with current good manufacturing practices (cGMP);

• Undeclared, toxic and unidentified ingredients found in vials as reported in the International Journal of Vaccine Theory, Practice and Research, 3 September 2022, which she discusses in detail;

• Concerning levels and patterns of adverse events associated with product lot numbers, differing across manufacturer, time and geographical area;

• Lack of accountability suggesting deliberate intent to harm, as supported by the Pfizer Documents Analysis Project, described by Dr Naomi Wolf on GBNews at 19m30s here and elaborated specifically in Dr Wolf’s discussion with Maajid Nawaz from 1h16m here);

• Extreme reproductive harms including significant foetal malformations in trials whilst “safety” is claimed by manufacturers without regulatory challenge;

• Bureaucratic structures show conflicting commercial interests and product co-ownership between the pharmaceutical industry and regulatory agencies;

• Major standard safety tests were and continue to be avoided; usual regulatory processes were not employed; and further testing will be avoided on the argument that mRNA vaccines are an approved “platform”, meaning changes to inserted genetic instructions can be made without regulatory input, with hundreds of new products planned.

• This slide is elaborated upon extensively and supports NZDSOS’ ongoing concerns regarding vial contamination; ( I posted the slide above)